Insights
Report Library
Browse our full archive of reports. Filter by health area, disease or condition, product, and date. Written by our expert analysts, our reports highlight key messages in the data, make the case for change and offer actionable recommendations.
20 min read
Flying Blind
This report provides a critical and timely landscape analysis of global R&D for endometriosis, polycystic ovary syndrome (PCOS) and uterine fibroids. In it, we evaluate and contextualise current investment, and review and analyse the pipeline of biomedical products developed and used to diagnose and treat them.
20 min read
Irresistible: developing new solutions for antimicrobial resistant STIs
In this report, we consider the future global response to three AMR-risk STIs: gonorrhoea, trichomoniasis and Mycoplasma genitalium. We analyse the funding that has been provided to research and develop new treatments, vaccines and diagnostics, and the resulting product pipeline for each of the three infections and their disease-causing pathogens.
20 min read
Mapping the Australian landscape for global health research
This is an in-depth analysis of Australia’s public sector funding for global health research from 2017 to 2023. As a high-income country, Australia has the potential to play a significant role in addressing global health challenges, especially within the Indo-Pacific region. The report highlights both the strengths and gaps in Australia’s global health research funding.
40 min read
The 2025 Neglected Disease R&D Pipeline review: Time to close the gaps
Amid reduced funding, political uncertainty, and rising infectious disease, this report assesses the health of the neglected diseases (ND) pipeline to empower funders, policymakers, and advocates to prioritize high impact investments. This report delves into a decade of ND pipeline insights to guide future investment strategies.
45 min read
A New Era? Funding for sexual & reproductive health R&D 2018-2023
This is the fourth in a series of reports summarising the state of global funding for LMIC-applicable biomedical research and development targeting a range of sexual & reproductive health and women’s health issues
10 min read
A stronger and safer United Kingdom through global health R&D investment: Foreword by Professor David Lalloo and Professor Liam Smeeth
The Vice-Chancellor of the Liverpool School of Tropical Medicine and the Director of the London School of Hygiene and Tropical Medicine reflect on Impact Global Health's research into the impact of UK investment in neglected disease R&D
40 min read
A stronger and safer United Kingdom through global health R&D investment
New research makes the investment case crystal clear: the UK's funding of neglected disease R&D saves lives, creates jobs and boosts the UK economy
15 min read
Strengthening Africa’s mpox diagnostic capacity for enhanced epidemic preparedness and response
This policy brief, developed in partnership with PATH, examines the current mpox diagnostic landscape in Africa.
45 min read
Global health R&D makes a strong investment case for Team Europe
Following on from our milestone report on the Impact of Global Health R&D, we launch a knowledge series looking at the investment case for specific regions. This report explores the impact of global health R&D funding from Team Europe.
You may also be interested in
Hubs
Your destination for a curated collection of data, insights and tools on the most pressing global health topics. Explore our hubs on Women’s Health, the Impact of Global Health R&D, and more to launch in the future.
Health Areas
Our Health Areas resource gives you an at-a-glance summary of the state of innovation and annual R&D investment by disease and condition. Updated regularly, this is a unique quick reference for the global health community.